Cart
sales@molnova.com
Ulipristal
CAS No. 159811-51-5
Ulipristal( Ulipristal | VA-2914 | ]PGL-4001 )
Catalog No. M18088 CAS No. 159811-51-5
Ulipristal is a selective SPRM for emergency contraception after an unprotected intercourse or contraceptive failure.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 42 | Get Quote |
|
| 5MG | 69 | Get Quote |
|
| 10MG | 110 | Get Quote |
|
| 25MG | 200 | Get Quote |
|
| 50MG | 332 | Get Quote |
|
| 100MG | 494 | Get Quote |
|
| 500MG | 1071 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameUlipristal
-
NoteResearch use only, not for human use.
-
Brief DescriptionUlipristal is a selective SPRM for emergency contraception after an unprotected intercourse or contraceptive failure.
-
DescriptionUlipristal is a bichemical.(In Vivo):Ulipristal (CDB 3236) may suppress the growth of uterine leiomyomatosis. By inhibiting or delaying ovulation and effecting endometrial tissue, ulipristal can be used as an emergency contraception.
-
In Vitro——
-
In VivoUlipristal (CDB 3236) may suppress the growth of uterine leiomyomatosis. By inhibiting or delaying ovulation and effecting endometrial tissue, ulipristal can be used as an emergency contraception.
-
SynonymsUlipristal | VA-2914 | ]PGL-4001
-
PathwayImmunology/Inflammation
-
TargetAntiviral
-
RecptorPR
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number159811-51-5
-
Formula Weight433.58
-
Molecular FormulaC30H37NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 250 mg/mL (576.59 mM)
-
SMILES[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
-
Chemical Name11beta-(4-(Dimethylamino)phenyl)-17-hydroxy-19-norpregna-4,9-diene-3,20-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Attardi BJ, et al. J Steroid Biochem Mol Biol, 2004, 88(3), 277-288.
molnova catalog
related products
-
Pirodavir
Pirodavir (R 77975) is the prototype of a novel class of broad-spectrum antipicornavirus compounds; potent human rhinovirus (HRV) capsid-binding inhibitor.
-
IM-250
IM-250 Possesses antiviral activity with IC values of 25 nM - 100 nM.
-
SARS-CoV-2-IN-39
SARS-CoV-2-IN-39 is a SARS-CoV-2 inhibitor with an EC50 of 1 μM. SARS-CoV-2-IN-39 has antiviral activity and inhibits SARS-CoV-2 by inhibiting SKP2 protein and stabilizing BECN1.
